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Abstract
Introduction: Over the recent years, the attention of scientists regarding the search for alternative means of treatment, 
including local therapy, of inflammatory skin diseases, has been focused in recent years on medicines containing ome-
ga-3 and 6 polyunsaturated fatty acids (PUFA).
Objectives: to substantiate the feasibility of using medicines containing omega-3 and 6 polyunsaturated fatty acids and 
antioxidants in the treatment of inflammatory skin diseases. 
Methods:The studies were carried out on 224 conventional white rats of the Wistar line in compliance with the interna-
tional principles of the European Convention for the Protection of Vertebrates. A burn injury was used to cause experi-
mental simple irritant contact dermatitis. After trying various treatment options with using Omegaven, histopathologi-
cal examinations of 18 fragments of affected skin of white rats with cross sections stained with hematoxylin–eosin and 
pikrofuxin by Van Gieson’s method. The state of lipid peroxidation (LPO) in blood and affected skin was evaluated in 
the animals. One hundred forty-six patients with inflammatory skin diseases (dermatitis simple irritant contact, allergic 
contact dermatitis, atopic dermatitis, neurodermatitis, psoriasis, cutaneous mastocytosis in children) were observed. In 
treatment, there were used medicines with omega-3 and 6 PUFA or an antioxidant medicines.
Results and discussion: Skin reactions of dermatitis simple irritant contact in rats after burn injury were evaluated at dif-
ferent points of time. The observations showed higher efficacy of medicines containing PUFA than standard anti-inflam-
matory agents in the treatment of simple irritant contact dermatitis. Histopathological examination of the skin of white 
rats with simple irritant contact dermatitis after the 11-day treatment revealed that the expression and composition of the 
cellular reaction in the lesions with a predominating lymphocytes and macrophages (mainly cell response) differ signifi-
cantly from those trated with Radevit ointment (segmented neutrophil leukocytes, eosinophils – delay in the acute phase 
of inflammation). There was identified a smaller thickness (up to 1/3) of the strips of granulation tissue under the actively 
proliferating cells of the epidermis. It was possible to demonstrate the superiority with respect to reducing the activity 
of LPO medicines containing omega-3 and 6 PUFA, over those with anti-inflammatory action. The clinical observations 
of patients showed high efficacy of the local treatment with medicines containing omega-3 and 6 PUFA, or antioxidant.
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Conclusion: For the first time, the mechanism of implementing an anti-inflammatory effect of the experimental med-
icines containing omega-3 and 6 polyunsaturated fatty acids (Omegaven, Vitamin F99 cream rich), – an antioxidant 
effect - when treating simple irritant contact dermatitis when treating simple irritant contact dermatitis; that is the weak-
ening of the severity of oxidative stress. For the first time, the greatest contribution of an increased activity of catalase 
to the weakening of oxidative stress in the affected skin is shown.
Keywords
skin, inflammation, polyunsaturated fatty acids, treatment.
Introduction
Improvement of local and systemic treatment of chronic 
skin diseases, including those with a significant patho-
genetic role of inflammatory reactions, is a highly urgent 
task at the moment (Kubanova and Akimov 2009). At the 
same time, alternative therapies are gaining momentum. 
A widespread and prolonged external use of corticos-
teroids to treat dermatitis can cause a number of nega-
tive effects: atrophy of the skin and subcutaneous adipose 
tissue, telangiectasia, hypertrichosis, erythrose, etc. In re-
cent years, the attention of researchers in the systemic and 
local treatment has been attracted to medicines containing 
omega-3 and omega-6 polyunsaturated fatty acids and an-
tioxidants (Kasichina 2015).
The term Vitamin F refers to the complex of fatty 
acids: linoleic, linolenic, arachidonic and their esters 
in Russian and foreign scientific literature. Among the 
tools of systemic therapy, the following ones containing 
polyunsaturated fatty acids were used: Alkanol, fish oil, 
eicosapentaenoic and docosahexaenoic acids, Polyene an-
tioxidant capsules, Eikovit capsules, biologically active 
supplement “Norvesol”, Eslidin capsules (Smirnov 2009, 
Kremer et al. 1995). As for the medicines of external use 
containing omega-3 and omega-6 PUFA, the authors used 
ointment containing 20 % PUFA with 0.5% antiseptic 
Dioxin to treat wounds and burns. Medicines containing 
vitamin F are Linetol and Eikonol. The composition of 
Eikovit gel includes internal fat of whitefish and salmon 
fish, containing PUFA, alpha-tocopherol, vitamins A, K 
with the action of anti-inflammatory, antioxidant, and 
wound healing effects. Omega-3 and 6 PUFA are contain-
ed in dermatic medicines made by Uriage company (Xe-
mose Universal Emollient Cream and Pruriced Cream).
Simple irritant contact dermatitis, allergic contact 
dermatitis, atopic dermatitis, neurodermatitis (focal and 
diffuse), psoriasis, urticaria pigmentation (ICD-10) are 
inflammatory skin diseases (Hehbif 2006). The diseases 
can be acute (simple irritant contact dermatitis, allergic 
contact dermatitis), or chronic (atopic dermatitis, neuro-
dermatitis, psoriasis, skin forms of mastocytosis in child-
ren). Acute inflammation, such as burns, can cause mild 
tissue damage, and chronic inflammation significantly af-
fects the functioning of the skin (Kasihina 2015).
Simple irritant contact dermatitis is a classic inflam-
matory skin disease, in which the acute phase is accom-
panied by erythema, vesiculation and itching. This skin 
inflammation is caused by contact with a damaging agent, 
such as, physical and thermal trauma, etc. (Kasihina 2015, 
Skripkin and Mordovcev 1999). 
The efficacy was noted when using a complex treat-
ment of dermatitis, eczema, psoriasis and other skin di-
seases by means of medicines containing omega-3 and 6 
PUFA (Ziboh 1989).
By the moment, a medicine for parenteral infusion 
containing PUFA has been developed – Omegaven emul-
sion. The indications for its use are: septicemia, thermal 
and chemical burns. Its pharmacological action: making 
up for the deficiency of polyunsaturated fatty acids (Gos-
tishchev et al. 2011, Gostishchev and Kosinets 2012a, 
Vyshkovskij 2016).
In the available scientific literature, there has been 
found no information on an experimental study on the 
model of simple irritant contact dermatitis if the effects of 
the systemic therapy by means of omega-3 and 6 PUFA, 
as well as by Vitamin F99 cream rich, including similar 
components. Neither has been covered the issue of a com-
parative study of the action of these medicines and Ra-
devit ointment, which is officially recommended to treat 
simple irritant contact dermatitis, on the intensity of skin 
inflammatory reactions. There is no literature data on the 
state of lipid peroxidation (LPO) in blood and affected 
skin of experimental animals in such a study. That was 
the reason to use it in the experiments the present stu-
dy is based on. Regarding the clinical phase of work, it 
concerned a local therapy to treat simple irritant contact 
dermatitis, allergic contact dermatitis, atopic dermatitis 
in children, focal and diffuse neurodermatitis, psoriasis, 
cutaneous forms of mastocytosis in children (inflammato-
ry skin disease) with medicines containing omega-3 and 
6 polyunsaturated fatty acids (Pruriced Cream, Xemose 
Universal Emollient Cream) or by thermal water by Uri-
age with the antioxidant, anti-inflammatory and skin hy-
drating effects (Bariederm Cream, Pruriced Gel, Cu-Zn 
cream, gel, spray, Keratosane-15 Lait-cream). No publi-
cations on the evaluation of either efficacy or safety of 
applying the above medicines in the local therapy to treat 
inflammatory skin diseases.
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LPO and antioxidant system (AOS) are in close con-
nection with inflammatory skin reactions. Free radicals 
constantly form during oxidation-reduction reactions: 
reactive oxygen species (superoxide-anion, singlet oxy-
gen form, hydroxyl radical, hydrogen peroxide), radicals 
which form during LPO (lipoperoxides), oxidized halo-
gens (chloramine, hypochlorite), and nitrogen oxide. Nor-
mally, LPO maintains the vitality of the body, participating 
in the protective (phagocytosis) and regulatory functions. 
The intensity of LPO processes in physiological conditi-
ons is regulated by a multi-stage complex system of AOS 
– enzymatic (specific) and non-enzymatic (non-specific) 
links. The system ensures the preservation and maintenan-
ce of the steady state of free radical processes (Dreev et 
al.1991, Rumleyand Paterson 1998, Knight 2000).
Superoxide dismutase (SOD), catalase (CAT) and glu-
tathione S-transferase are the main components of the 
LPO. The system enables free-radical processes to pro-
ceed at the optimal level (Winterbourn 1989). As for the 
AOS-protection in skin, the system mainly consists of the 
enzymes: CAT, SOD, glutathione peroxidase (Ketsa and 
Shved 2014, Fridovich 1983, Ghadially et al.1996, Bycz-
kowski and Gessner1998, Ratnam et al. 2006).
Purpose of research
In the experiment, to substantiate and clinically confirm 
the feasibility of using PUFA medicines and antioxidants 
in the treatment of inflammatory skin diseases.
Methods
The studies were carried out on 224 inbrand conventio-
nal white Wistar rats aged 3-6 months weighing 300-350 
g in compliance with the international principles of the 
European Convention for the Protection of Vertebrates, 
taking into account the rules of biomedical ethics (with 
the permission of Rostov Ethics Committee, Protocol No. 
16/13 dated 14.11.2013) (Karkichenko N.N., Grachev S. 
V., 2010). A burn injury was caused by a circular metal 
plate with an area of 3.8 cm2,  1.5 mm thick, and the con-
tact with the skin was 3 seconds. The plate was heated in 
two ways: on a spiral-covered electric stove at the initial 
signs of redness of the metal part covering the spiral (pro-
nounced burn injury, 200 degrees C) and after a 20-se-
cond cooling on a metal plate of the room temperature 
(moderate burn injury, 120 degrees C).
Omegaven was injected into the abdomen of white rats 
at a dose of 3.0 ml/kg daily in the form of emulsion for in-
fusion, and Radevit ointment and Vitamin F99 cream rich 
were also applied daily to the lesions with swabs. For the 
prevention of pyoderma, once every 3 days, Erythromy-
cin ointment was applied onto the foci. During the expe-
riment, the recommendations of the International Contact 
Dermatitis Research Group were modified (Kasambas 
and Lotti 2008). The reaction was estimated as a sharply 
positive (3+), if the thickness of the edematous infiltrate 
was 3 mm or more, positive (2+) with edematous infil-
trate from 1 to 2 mm, or weakly positive reaction (1+) 
– with the infiltrate thickness of 1 mm or less. The cor-
rective coefficient for 3+ was 1.0, for 2+ – 0,66, and for 
1 – 0.33. The half sum of the two orthogonal diameters 
or the area of the inflamed lesion was multiplied by a 
corrective coefficient, obtaining an indicator in corrected 
diameter units (CDU) or corrected area units (CAU) (Gre-
bennikov et al. 1978). There were the following groups 
of animals: control group (without simple irritant contact 
dermatitis), group 1.1 (simple irritant contact dermatitis 4 
days without treatment), group 1.2 (simple irritant contact 
dermatitis 11 days without treatment), group 2 (On the 
second day after the burn, Radevit ointment was applied 
onto the foci. Radevit ointment is an officially recom-
mended anti-inflammatory medicine for the treatment of 
simple irritant contact dermatitis.), group3 (The animals 
of the 3rd group received two manipulations daily for 11 
days: injections of Omegaven emulsion into the abdomi-
nal cavity, as well as application of Vitamin F99 cream 
rich onto the foci.), group 4 (the animals were treated only 
with  Vitamin F99 cream rich). The main active ingredient 
of Omegaven is highly purified fish oil, containing PUFA.
In the available scientific literature, there have benn no 
reports found on the effect of Omegaven on the inflam-
matory reaction of the skin. However, it is the only drug 
containing PUFA for parenteral administration. Thus, it 
explains the novelty of the present research.
Vitamin F99 cream rich (Research Laboratory Strelets 
Ltd, Russia) includes vitamin F as a source of essential po-
lyunsaturated fatty acids and esters of omega-3 fatty acids. 
Radevit ointment (Retinoids, Russia), with anti-inflamma-
tory action, applied in group 2, enhances the protective 
function of the skin. The indications include burns, aller-
gic contact dermatitis, and inflammatory skin diseases. 
Histopathological examinations of 18 fragments of af-
fected skin of the experimental white rats with with fu-
rther staining the cross sections with hematoxylin–eosin 
and pikrofuxin by Van Gieson’s method. The AOS state 
in blood and skin extracts was assessed by determining 
the content of Malondialdehyde (Stalnaya and Garishvili 
1977), the activity of superoxide dismutase (Mistra and 
Fridovich 1972) and of catalase (Korolyuk et al. 1988).
In the clinical studies to evaluate the effectiveness of 
local therapy that contains omega-3 and 6 PUFA, with 
either antioxidant, anti-inflammatory, or skin hydrating 
effects, 146 patients were observed with inflammatory 
diseases of the skin, 44% males and 56% females, aged 
from 2 months to 83 years. Among them, 22 patients 
were diagnosed with simple irritant contact dermatitis, 32 
patients – with allergic contact dermatitis, 28 children – 
with, atopic dermatitis, 13 patients – with neurodermatitis 
(focal and diffuse), 28 patients – with psoriasis, and 23 
children – with a cutaneous form of mastocytosis. Assess-
ment of the severity of atopic dermatitis – SCORAD, and 
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a PASI index applied in the study is the basic standard for 
assessing the severity of psoriasis. Family Dermatology 
Life Quality Index (FDLQI) and HAM (health-activi-
ty-mood) index were used to assess a psychological state 
of patients with dermatoses.
The obtained data were processed by the method of va-
riation statistics and calculation of arithmetic mean values 
(M) and errors of average values (m). The significance 
was evaluated by Student’s criterion (t), and differences 
were considered reliable at the probability level of more 
than 95% (P<0.05).
Results and discussion
Skin reactions (simple irritant contact dermatitis) after 
a burn injury were evaluated after 1 day, and then after 
4 days, 7 days, and 11 days (Table 1). After this period, 
the manifestations of simple irritant contact dermatitis in 
most animals were insignificant.
In severe burn injury in rats of group 1.2 after 4 days 
without treatment, the indicators were 22.85±0.43 CDU. 
and 4.12±0.15 CAU. The observation in group 3 with sim-
ple irritant contact dermatitis treated by a combination of 
Omegaven injection and, externally, Vitamin F99 cream 
rich showed consistent dynamics with a 1.15-time incre-
ased inflammatory reaction of the skin from day 1 to day 4 
(P<0,05 in terms of the corrected area). Further, under the 
influence of treatment, by day 7 the skin reaction became 
1.5-time weaker than that after 4 days according to the aver-
age corrected diameter and corrected area (P<0.001). The 
manifestations of simple irritant contact dermatitis were sig-
nificantly weakened by day 11 of treatment: they were 2.5-
time (P<0.001) less intense and 3-time (P<0.001) less inten-
se than after 4 days, and when compared with the indicators 
after 7 days, 1.7 times and 2 times (P<0.001), respectively.
The comparison of group 3 indicators (7 days)) and 
groups 3 (11 days).) with those in groups 2 (7 days) and 
2 (11 days) showed in group 3 after 7 days of treatment 
1.2-time less pronounced inflammatory reactions of the 
skin (P<0.05) and by 1.25 times (P<0.05). In the same 
group 3 after 11 days of treatment, the intensity of in-
flammatory skin reactions was 1.8-time (P<0.001) and 
2.5-time (P<0.001) lower than in group 2 (11 days.). This 
demonstrates the advantage of complex anti-inflammato-
ry treatment with Omegaven  and Vitamin F99 cream rich 
compared to that with Radevit ointment. The advantage 
increased by day 11.
After 7 days of observation in group 3, the indicators 
were 1.5-time lower than those in group 3 (4 days) - more 
convincing than in group 2 for the 7 days of observation 
– significantly (1.2 times).
The severity of simple irritant contact dermatitis in 
group 3 (7 days) was less than in group 2 (7 days). After 
11 days of treatment, the indicators of group 3 were 1.8-
time (P<0.001) and 2.15-time (P<0.001) lower than those 
in group 2 (11 days), that is, treatment by day 7 and day 11 
was more effective in group 3 than in group 2.
Eleven days after the development of simple irritant 
contact dermatitis, the indicator of the group without 
treatment (group 1.2) exceeded (P<0.05) that 1.2 times 
with an estimate of the corrected diameter when using 
the treatment with Radevit (group 2), and 2.1 times when 
using treatment with Omegaven and Vitamin F99 cream 
rich (group 3) and 1.4 times when compared with group 
4. A similar pattern was noted when assessing by means 
of corrected area units.
The indicators of group 3 were significantly less than 
those in groups 3 (4 days) and 3 (7 days), and also those 
in group 2 (11 days) treated with Radevit ointment –1.8 
times (P<0.001) and 2.2 times (P<0.001) after 11 days of 
treatment of simple irritant contact dermatitis in white 
rats. A similar pattern was revealed when comparing the 
indicators of group 3 (11 days) and 4 (11 days). Group 3 
indicators (11 days).) were 1.5-time (P<0.001) and 1.7-
time (P<0.001) less pronounced. Thus, the higher effi-
ciency is obvious when treating simple irritant contact 
dermatitis with Omegaven and Vitamin F99 cream rich 
than when treating it with Radevit ointment and Vitamin 
F99 cream rich. When making an experiment with simple 
irritant contact dermatitis after a moderate burn injury, all 
the above mentioned regularities of the dynamics of the 
simple irritant contact dermatitis under the influence of 
different 3-treatment options repeated.
The observations showed higher efficiency of medi-
cines containing PUFA (Omegaven, Vitamin F99 cream 
rich) than Radevit ointment of group 2, in the treatment 
of simple irritant contact dermatitis in experimental white 
rats. The combination of Omegaven and Vitamin F99 
cream rich for an anti-inflammatory effect on the foci of 
simple irritant contact dermatitis was more significant 
than the action of only Vitamin F99 cream rich. 
Table 1. Skin reactions in simple irritant contact dermatitis (severe burn injury) in corrected diameter units
Groups of experimental white rats (n = 20)
Severity of simple irritant contact dermatitis at different periods after burn
After 1 day, CDU After 4 days, CDU After 7 days, CDU After 11 days, CDU
Group 1.2 – simple irritant contact dermatitis, 
11 days without treatment 21.30±0.39 22.85±0.43, 2* 22.20±0.61, 4* 19.70±0.52*, 4*
Group 2 –Radevit ointment 20.09±0.92 21.90±0.86 19.04±0.60*, 4* 16.60±0.44*, 3*, 4*
Group 3 –Omegaven&Vitamin F99 cream rich 22.42±0.92 23.20±0.22 15.59±0.49*, 3* 9.20±0.56*, 3*
Group 4 –Vitamin F99 cream rich 22.07±0.55 24.50±0.38* 16.68±0.63*, 3* 14.07±0.21*, 3*, 4*
Note. The differences are significant (P<0.05): with group 1.2 (4 days) – *, with an indicator of “its own” group (1 day) –2*, with an indicator of “its 
own” group (4 days) – 3*, with indicators of group 3 after 7 or 11 days, respectively, – 4*. The reliability of other comparisons is given in the text.
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The histopathological examination of the skin of 
white rats with simple irritant contact dermatitis after 
11-day treatment with Omegaven injections into the ab-
dominal cavity and with external use of Vitamin F99 
cream rich allowed to note less pronounced infiltrates 
and a different cell reaction in the foci with predom-
inating lymphocytes and macrophages than in those 
treated with Radevit ointment (neutrophil segmentonu-
clear leukocytes, eosinophils – delay of the acute phase 
of inflammation). A smaller thickness (up to 1/3) of a 
granulation tissue strip under the actively proliferating 
epidermal cells was also revealed. This will probably 
lead to the formation of a more delicate scar. There was 
a more pronounced anti-inflammatory effect in exper-
imental treating simple irritant contact dermatitis with 
Omegaven injections into the abdominal cavity and ex-
ternal use of Vitamin F99 cream rich compared to those 
treated with Radevit ointment.
There is a close connection between PUFA and AOS 
in the body. It was found that omega-3 PUFA have an 
antioxidant effect (Ketsa and Shved 2014). According to 
(Shepelev and Shovkun 2012), through the stage of PUFA 
derivatives occurs the biosynthesis of prostaglandins (PG) 
and leukotrienes (LT).
Among the final AOS products Malondialdehyde 
(MDA) plays the leading role in the formation of com-
plexes, and the antioxidant protection system in the skin 
includes mainly antioxidant enzymes SOD, CAT, etc.
The MDA content, the activity of SOD and CAT were 
evaluated in the blood of white rats with severe burn inju-
ry in different treatments (Table 2).
In group 3 of white rats (they received 2 medicines that 
contain omega-3 and 6 PUFA) after 11 days of therapy, the 
MDA rate was higher than the control and 1.1 groups (in 
group 2 after treatment with Radevit ointment, the MDA 
rate was 1.4- and 1.3-time higher than that in the control 
and 1.1 groups, respectively). The activity of blood SOD 
was 2.8-time higher than that in group 1.1 (simple irritant 
contact dermatitis without treatment – 4 days), and CAT 
was 1.5 times higher. The tables show that the comparison 
of blood  LPO group 1.2 (simple irritant contact derma-
titis without treatment –11 days) and group 3 (combined 
treatment with Omegaven and Vitamin F99 cream rich – 
11 days) revealed less pronounced activation of LPO in 
group 3 and, on the contrary, the prevailing  activity of 
SOD and CAT.
Particular attention is drawn to the excess of CAT ac-
tivity in group 3 compared to group 2 (Radevit ointment 
treatment) by1.3 times. For all 3 studied components of 
LPO and AOS, the indices of the 3rd group were more 
favorable than in the 2nd group. Thus, the treatment of 
dermatitis simple irritable  contact with medicines contai-
ning omega-3 and 6 PUFA (Omegaven, Cream “Vitamin 
F99” rich), was more effective than the anti-inflammatory 
activity of Radevit ointment.
In experimental dermatitis simple irritable contact in 
white rats oxidative stress was noted.There is AOS de-
compensationwhich remained until significant clinical 
stabilization in the foci of severe burn injury. The most 
effective in relation to the state of AOS was a combina-
tion of Omegaven and Cream “Vitamin F99” rich. So it 
was possible to demonstrate the superiority with respect 
to the activity of AOS medicines containing omega-3 and 
6 PUFA, over medicines of anti-inflammatory action (Ra-
devit ointment).
We found it advisable to evaluate the content of MDA 
in the affected skin from the foci of inflammation, as well 
as the activity of SOD and CAT in the process of local tre-
atment using the following means: Radevit ointment an-
ti-inflammatory action, as well as Cream “Vitamin F99” 
rich Containing omega-3 and 6 PUFA (the most pronoun-
ced beneficial effect on the state of the blood AOS of the 
combination of injections of Omegaven and externally 
Cream “Vitamin F99” rich has already been convincingly 
demonstrated above).
The experiments were conducted in parallel with se-
vere burn injury (experiment 1) and with moderate burn 
injury (experiment 2). The results are presented in Tables 
3 and 4. 
The content of MDA 4 days after a severe burn injury 
(without treatment) increased sharply (147.9±4.4 nmol/g 
– 2.3 times; P<0.01). The indices of experiments 1 excee-
ded 1.4 times those of experiment 2 (P<0.05). The reason 
was the difference in the severity of burn injury. 
Clear dynamics in all 3 groups of treatment in both 
variants of the experiment was shown by the activity of 
CAT of the affected skin, which significantly increased. In 
a severe burn injury, CAT activity increased 1.5 times in 
group 1.1 (P<0.001), 1.5 times in group 2 (P<0.001), .1.7 
times in group 4 (P<0.001). Accordingly, with a moderate 
burn injury, CAT activity increased 1.7 times in group 1.1 
(P<0.001), and 1.5 times in groups 2 and 4 (P<0.001).
Table 2. Сomponents of the antioxidant system of blood of rats with simple irritant contact dermatitis (severe burn injury)
Groups of experimental white rats (n = 20) МDА [nmol/ml] SOD [RU/ml] CАТ [U/ml х min]
Control group – without simple irritant contact dermatitis 6.23 ±0.26 23.83±0.94 44.31±1.81
Group 1.1 – simple irritant contact dermatitis, 4 days 
without treatment 7.06±0.26*, 3* 11.81±0.57*, 3*, 4*, 5* 33.55±0.75*
Group 1.2 – simple irritant contact dermatitis, 11 days 
without treatment 10.30±0.25*, 2*, 4*, 5* 15.79±1.01*, 2*, 4*, 5* 35.00±1.46*, 5*
Group 2 – Radevit ointment – 11 days 8.80±0.24*, 2*, 3* 32.30±3.18, 2*, 3* 38.60±0.47*, 2*, 5*
Group 3 – Omegaven&Vitamin F99 cream rich – 11 days 7.88±0.28*, 3* 33.42±3.11, 2*, 3* 48.60±1.17*, 2*, 3*, 4*
Note. Significant differences( p<0.05): with control group - *; with group 1.1 – without treatment 4 days –2*; with group 1.2 – without treatment 11 
days –3*; with group 2 – 4*, with group 3 – 5*. The reliability of other comparisons is given in the text.
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Much less definite in both versions of the experiment 
was the activity of SOD. In groups 1.1 in both variants 
of the experiment in terms of the indicators of MDA and 
SOD, there was found out, decompensation of the LPO 
and AOS systems (oxidative stress), according to the in-
dicators of CAT of the affected skin, the signs of compen-
sation of these systems were revealed. 
In both variants of the experiment in 4 groups com-
pared with groups 1.1, the activity of SOD was 1.3 times 
and by 1.5 times higher, respectively.. Thus, the reliable 
compensation of AOS was established due to a relatively 
increased activity of SOD in 4 groups in addition to an 
increased activity of CAT of the affected skin – 1.7 times 
in the group with a severe burn injury and 1.5 times in 
the second version of the experiment. There was no such 
a favorable dynamics of the leading components of the 
LPO in group 2. The comparison of LPO indicators in the 
affected skin in group 1.2 (11 days without treatment) and 
group 4 (treatment with Vitamin F99 cream rich) revealed 
prevalent activity of SOD and CAT in group 4 with severe 
and moderate burn injuries.
The analysis of interrelation between LPO and AOS 
in blood and affected skin with simple irritant contact 
dermatitis in the experimental white rats revealed certain 
patterns in different methods of treatment. In the study of 
blood, the most effective in relation to the LPO and AOS 
states was the treatment with a combination of Omegaven 
and Vitamin F99 cream rich.
By the 4th day after a severe burn injury (without treat-
ment), there was recorded  decompensation in the LPO 
blood system – oxidative stress. With the continuing in-
flammatory reaction of the skin in the foci of simple ir-
ritant contact dermatitis, although significantly reduced 
after 11 days of treatment, along with signs of oxidative 
stress (increased MDA), there were clear manifestations 
of compensation of the LPO system (relative increase in 
the activity of SOD and CAT of blood).
The data obtained justify the use of external and syste-
mic medicines containing omega-3 and 6 PUFA, as well 
as antioxidants in the treatment of skin diseases with an 
inflammatory component of pathogenesis (simple irritant 
contact dermatitis, allergic contact dermatitis, atopic der-
matitis, neurodermatitis, psoriasis, skin form of mastocy-
tosis in children). The period of using PUFA and antioxi-
dants is from the exacerbation of skin diseases and further 
to rashes with the weakening of the signs of inflammatory 
reaction of the affected skin – erythema, swelling, infiltra-
tion, and itching.
The authors together with a group of dermatologists 
participated in the treatment, assessment of the severity 
of diseases, analysis of the dynamics of symptoms, the 
results of treatment, including long-term ones, using to-
gether local therapeutic agents omega-3 and 6 PUFA, as 
well as thermal water  Uriage with antioxidant, anti-in-
flammatory, and skin hydrating effects. Systemic treat-
ment was traditional in accordance with modern Federal 
clinical guidelines on dermatology (Russian Federation) 
(Kubanova 2016). Omega-3 and 6 PUFA were adminis-
tered topically in form of Pruriced  Cream and Xemose 
Universal Emollient Cream, and thermal water Uriage 
was prescribed in in form of Bariederm Cream, Pruriced 
gel, Cu-Zn cream, gel, spray, Keratosane-15 Lait-cream 
(Uriage, France). 
There were 2 groups of patients with skin diseases. To 
treat skin diseases, the patients of the 1st group used Ba-
riderm Cream containing thermal water Uriage. In the 1st 
Table 4. LPO indicators of affected skin of white rats with simple irritant contact dermatitis (“moderate burn injury”)
Groups of white rats
(n=20) МDА [nmol/ml] SOD [RU/ml] CАТ [U/ml х min]
Group control – without simple irritant contact dermatitis 63.15±5.0 589.6±31.7 20.50±1.49
Group 1.1 –  simple irritant contact dermatitis, 4 days 
without treatment 107.4±11.2*, 3* 468.2±69.4 33.78±1.70*, 3*
Group 1.2 –  simple irritant contact dermatitis, 11 days 
without treatment 148.8±14.1*, 2* 493.3±30.8 24.75±1.93, 2*
Group 2 – Radevit ointment 11 days 113.2±24.6 531.6±95.1 30.92±1.03*, 3*
Group 4 – Vitamin F99 cream rich 11 days 139.6 ±16.3* 682.2±44.7, 2*, 3* 29.90 ± 1.80*
Note. Differences are significant (P<0.05): with control group - *;  with group 1.1 without treatment 4 days after burn injury – 2*; with group 1.2 
without treatment 11 days –3*. The reliability of other comparisons is given in the text.
Table 3. LPO system indicators of the affected skin of white rats with simple irritant contact dermatitis (“severe burn injury”)
Groups of white rats (n = 20) МDА [nmol/ml] SOD [RU/ml] CАТ [U/ml х min]
Group control – without simple irritant contact dermatitis 63.15±4.44 589.6±26.7 20.50±1.26
Group 1.1 – simple irritant contact dermatitis, 4 days 
without treatment
147.9±4.4*, 3* 453.0±32.1* 30.84±0.86*, 3*
Group 1.2 – simple irritant contact dermatitis, 11 days 
without treatment
171.3±4.0*, 2* 459.9±15.3*, 6* 25.30±0.54*, 2*, 4*, 6*
Group 2 – Radevit ointment, 11 days 164.1±6.3* 470.1 ±41.8* 30.49±0.97*, 3*
Group 4 – Vitamin F99 cream rich, 11 days 142.6±8.0*, 4* 597.6±14.6, 2*, 3* 33.92±0.67*, 3*, 4*
Note. Differences are significant( p<0.05): with control group – * , with group 1.1 without treatment 4 days after burn injury – 2*, with group 1.2 
without treatment 11 days –3*. The reliability of other comparisons is given in the text.
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subgroup (1st Group), there were 22 young women who 
in the winter season had simple irritant contact dermatitis 
exposed by wind and cold (dry skin, erythema, peeling, 
cracks). In the morning, 15 minutes after using cosmetic 
cream, they applied Bariederm Cream to the foci of irri-
tation; if necessary, this was repeated in the 2nd half of the 
day. All women in this subgroup recovered.
In the 2nd subgroup (1st Group), there were 32 patients 
with allergic contact dermatitis (12 doctors, 7 hairdres-
sers, 4 housewives exposed to a negative impact of home 
care products, 9 patients of other professions). Five peop-
le had allergic contact dermatitis from exposure to cosme-
tic products, 4 patients had a skin reaction to dyed fabric 
in the points of contact with tights or jeans, 3 patients had 
a skin reaction to metal zippers and buckles. The reactions 
were mostly erythematous lesions with some swelling, in-
filtration of the skin, peeling, sometimes with vesicular or 
crusted elements with itching. The duration of the disease 
was from 4 weeks to 6 months. In the treatment of allergic 
contact dermatitis, Advantan was prescribed, and 15 mi-
nutes after its application, Bariederm Cream was applied. 
After 10 days, Advantan was discontinued, and then only 
Bariederm Cream was used 2-4 times a day. The patients 
were observed to recover, without any adverse events 
from treatment. There was recorded no recurrence of al-
lergic contact dermatitis from 2 to 12 in 28 patients(88%), 
and the disease was in a mild form in 4 cases.
In the 3rd subgroup (1st Group), 23 children under 5 
years of age with cutaneous forms of mastocytosis were 
observed. Thirteen children had bullous form, ,5 children 
had papular form, 5 patients had macular form. The most 
frequent symptoms were small rounded reddish-brownish 
spots, or several yellowish-brown swollen papules sym-
metrically arranged; when rubbing –Darier’s symptom. 
Systemic therapy to stop the activation of skin forms of 
mastocytosis was supplemented locally with non-steroi-
dal drug Pimecrolimus Cream 1%, selectively inhibiting 
the synthesis and release of inflammatory mediators by 
mast cells. Pimecrolimus was applied at the first signs of 
activation of the elements. Such a treatment quickly redu-
ced or led to a complete regression of the inflammatory 
response. To prevent the activation of mastocytosis from 
exogenous trigger factors (friction, atmospheric effects, 
bathing), in a non-acute phase, Bariederm Cream, protec-
ting skin from aggressive environmental factors, was ap-
plied to the areas of rashes in the children twice a day. The 
treatment reduced the frequency of activation of masto-
cytosis elements (according to the parents’ observations, 
7-8-fold). For the period from 4 weeks up to 14 months, 
no undesirable side effects were found. The results of tre-
atment were regarded as an improvement (which is very 
important in this disease). Life quality improvement of 
the sick children’s mothers was statistically signi: from 
28.00±0.38 to 10.00±0.50 points (P<0.001; FDLQI).
In the 2nd group, there were patients with inflammato-
ry dermatoses, who along with standard systemic therapy 
used external medicines containing omega-3 and 6 PUFA, 
or thermal water Uriage.
In the 1st subgroup (2nd Group), there were 13 patients 
with neurodermatitis (focal and diffuse), the leading 
symptom of which was persistent intense itching. Focal 
neurodermatitis was more often localized on the back and 
sides of the neck, in 3 characteristic zones on ankle joints. 
With diffuse neurodermatitis, the patients had numerous 
miliary slightly pink itchy papules, erythema, swelling, 
infiltration, lichenification in the elbow and knee folds, 
on the neck, radiocarpal joints, etc. The skin was dry and 
grayish. Standard systemic therapy was administered in 
all the patients, and topically – Cream or Pruriced gel –
depending on the localization of the lesions on the skin or 
hairy part of the head, as well as the severity of inflam-
mation. On the first, day positive effect was observed to 
some extent in 12 people (94%). Two weeks later, itching 
completely stopped in 6 patients, significantly decreased 
in 4 and decreased in 3 people. Monitoring of patients for 
6 months showed that with the disappearance of itching 9 
people stopped applying Pruriced, and the rest continued 
to use it much less frequently. A high effect of using Pruri-
ced in atopic eczema (focal and diffuse) was also recor-
ded, without the use of topical corticosteroids.
In the 2nd subgroup (2nd group), there were 28 child-
ren with atopic dermatitis (mild to moderate form), in 
treating whom antioxidant, ant-inflammatory, antiseptic 
agents, such as Cu-Zn cream, gel or spray were used. 
The age of the sick children varied from 2 to 16 years. 
Cu-Zn cream or spray (for moist areas; gel-for hygienic 
procedures) daily 2 times a day on foci in addition to 
standard systemic therapy was prescribed to 17 children 
(index SCORAD 49.00±1.5 points), another 11 people 
(index SCORAD 50.0±2.3 points) received traditional 
treatment without Cu-Zn cream. The effectiveness of 
therapy was evaluated after 2 weeks and 6 months. After 
a 2-weeks treatment of the patients with Cu-Zn cream, 
SCORAD index decreased (P<0.01) to 23.0±1.4 points, 
and in the subgroup of comparison – to 29.0±1.6 points 
(1.3 times higher; P<0.05). Among those who used 
Cu-Zn cream rashes completely resolved in 4 patients 
(24%), in the rest there was a significant improvement. 
In the subgroup of comparison, a significant improve-
ment was in 5 patients (46%), in the rest of the children, 
there was only improvement. The long-term results were 
more favorable among those who used Cu-Zn cream in 
treatment.
In the 3rd subgroup (2nd Group), there were 19 patients 
with psoriasis with frequent relapses. The majority of 
the patients had acute dermatosis 3 times a year or more 
(PASI index on average29.7±1.1). In addition to standard 
treatment, including topically external corticosteroids, 
the patients used Keratosane-15 Lait-cream with 2-3 ap-
plications per day. Keratosane-15 Lait-cream contains 
antioxidant thermal water Uriage. After 2 weeks of the 
therapy, improvement was recorded in a 50% decrease in 
PASI. After 4 weeks of treatment, clinical remission was 
achieved in 70% of the patients, a significant improve-
ment in 12% of the patients; the average value of PASI 
was 5.8±0.9 (a 5.1-time decrease; P<0.01).
Research Result: Pharmacology and Clinical Pharmacology 4(2): 85–93 
Grebennikova SV & Maklyakov YS: Experimental and clinical study of  the efficacy ...92
In the 4th subgroup (2nd Group), there were 6 patients 
with psoriasis who underwent local treatment with Xe-
mose Universal Emollient Cream in the complex thera-
py. This cream contains omega 3 and 6 PUFA, thermal 
water Uriage, etc. The patients were with a disease his-
tory from 1 year to 26 years. Xemose Universal Emol-
lient Cream was used externally on rash of the left half 
of the body, and the symmetrical lesions of the right half 
of the body were treated with an indifferent lanolin-ba-
sed cream. Treatment was started in the stationary sta-
ge (PASI index on average 13.0±3.1). Five patients had 
over 10% of the skin affected, 1 patient had 5% of the 
skin affected. Treatment resulted in a significant decrease 
in the PASI index to 3.0±0.6 (4.3 times). There was a 
significant reduction in itching (by 93%), infiltration of 
affected skin (by 83%), erythema (by 62%), and peeling 
(by 60%). According to the HAM test, the improvement 
of health indicators increased from 4.5 to 5.3 points, acti-
vity indicators changed from 5.1 to 5.6 points, and mood 
indicators changed from 5.6 to 5.7 points. Upon comple-
tion of the course of treatment, a good subjective tolera-
bility of Xemose Emollient Universal Cream was esta-
blished; it was easy to apply, had good absorbency, soft 
texture, quick moisturizing effect lasting for 12 hours; 
it gave no feeling of “oily film”, which was characte-
ristic of an indifferent cream. In the areas of the skin on 
which Xemose Emollient Universal Cream was applied 
(left half of the body), the color of the rash elements was 
less bright; there was less infiltration and peeling, and the 
skin was more elastic, less dry than on the right half of 
the body (where an indifferent cream was used).
Conclusion
For the first time, the mechanism of implementing an 
anti-inflammatory effect of the experimental medicines 
containing omega-3 and 6 polyunsaturated fatty acids 
(Omegaven, Vitamin F99 cream rich), – an antioxidant 
effect – when treating simple irritant contact dermatitis; 
that is the weakening of the severity of oxidative stress. 
(decompensation in the lipid peroxidation system). For 
the first time, the greatest contribution of an increased 
activity of catalase to the weakening of oxidative stress 
in the affected skin is shown. Histopathological analysis 
revealed that, when treating experimental simple irritant 
contact dermatitis with Omegaven injections into the 
abdominal cavity and externally with Vitamin F99 cream 
rich, the infiltrates were less pronounced and there was a 
different composition of the cellular reaction in the les-
ions with predominating lymphocytes and macrophages 
than in those treated with Radevit ointment, which were 
characterized by a delayed acute phase of inflammation. 
The expediency of using Omegaven parenterally and the 
means of local therapy with omega-3 and 6 PUFA to treat 
inflammatory skin diseases is substantiated. Omegaven 
drug was used in the experiment according to the new cli-
nical indications in simple irritant contact dermatitis
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